Apr. 5 at 7:12 PM
$NAGE Jeff
@u_k1hzsp54sljg
17h
With Niagen Plus now being offered on about 200 cruise ships, how might that affect the company's bottom line? Just for speculation, let's assume that for each travel day *assuming that ships average about 340 days at sea per year, some with 3,000 or more passengers, and that 6 IVs are given per day, with Niagen Bio netting about
$50 each. Since the manufacturing, shipping, marketing on the ships, and administration of the IVs are not being paid for by Niagen Bio, I am assuming in the calculation that it will have no costs or very limited costs in this program. 200 ships x 340 days x 6 IVs x
$50 =
$20,400,000. That would more than double the company's most recent year's net income (
$17.4 M). In addition, people who get the IVs will continue to do so on land or start taking TruNiagen capsules. (continued as a reply)
0
Comment
2
